A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries

by Kolawole Salami, Nathalie Imbault, Aljoscha Erlebach, Johanna Urban, Mike Zoglowek, Nadia G. Tornieporth
Published 2020-02-01

A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children.

by Sabine Bélard, Saadou Issifou, Aurore B Hounkpatin, Frieder Schaumburg, Ulysse Ateba Ngoa, Meral Esen, Rolf Fendel, Pablo Martinez de Salazar, Raymund E Mürbeth, Paul Milligan, Nathalie Imbault, Egeruan Babatunde Imoukhuede, Michael Theisen, Søren Jepsen, Ramadhani A Noor, Brenda Okech, Peter G Kremsner, Benjamin Mordmüller
Published 2011-01-01

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.

by Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bhardwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh, Virander S Chauhan
Published 2015-01-01

Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.

by Chetan E Chitnis, Paushali Mukherjee, Shantanu Mehta, Syed Shams Yazdani, Shikha Dhawan, Ahmad Rushdi Shakri, Rukmini Bhardwaj, Puneet Kumar Gupta, Dhiraj Hans, Suman Mazumdar, Bijender Singh, Sanjeev Kumar, Gaurav Pandey, Varsha Parulekar, Nathalie Imbault, Preethi Shivyogi, Girish Godbole, Krishna Mohan, Odile Leroy, Kavita Singh, Virander S Chauhan
Published 2015-01-01